We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
120 hedge funds and large institutions have $1.94B invested in Atara Biotherapeutics in 2019 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 52 increasing their positions, 38 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
250% more call options, than puts
Call options by funds: $7.58M | Put options by funds: $2.16M
37% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 38
16% more capital invested
Capital invested by funds: $1.68B → $1.94B (+$264M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% more ownership
Funds ownership: 4.23% → 4.23% (+0%)
1% less funds holding
Funds holding: 121 → 120 (-1)
6% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 16
Holders
120
Holders Change
-1
Holders Change %
-0.83%
% of All Funds
2.6%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
15
Increased
52
Reduced
38
Closed
16
Calls
$7.58M
Puts
$2.16M
Net Calls
+$5.42M
Net Calls Change
+$2.33M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$42.5M |
| 2 |
MC
Maverick Capital
Dallas,
Texas
|
+$32.4M |
| 3 |
JP Morgan Chase
New York
|
+$24.9M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$20.4M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$10.8M |
Top Sellers
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$53.5M |
| 2 |
Morgan Stanley
New York
|
-$20.4M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$19.2M |
| 4 |
BM
Bridger Management
New York
|
-$16.9M |
| 5 |
HCM
Highline Capital Management
New York
|
-$8.96M |
